Ningbo Renjian Pharmaceutical Co., Ltd., founded in 1988, is a high-tech enterprise specialized in manufacturing biochemical drugs, synthetic pharmaceutical intermediates, APIs and preparations. It has a staff of 500, in which technical personnel is more than 130. More than 90% of the products are exported to Europe, America, Japan, Southeast Asia, etc. The company has the honor to receive many awards such as “Top Export Enterprises of Ningbo”, “Technology Advancement Enterprises of Cixi”, “Model Enterprises for Science and Technology Innovation of Cixi”, “High Technology and New Technology enterprises of Cixi”, “High Technology and New Technology enterprises of Zhejiang Province 2002”The company's R&D center is evaluated “Provincial High Technology and New Technology Research and Development Center”.Biochemical APIs and Preparations: The manufacturing site, located at 555 Changchi Road in Cixi, occupies a land area of 40,000 square meters. It started operation in 2004 and passed GMP inspection in the same year. It has a good environment, professional layout and flow, adanced facilities. It produces APIs such as chorionic gonadotropin (hCG), menotropins (hMG), heparin sodium, oxytocin solution, powdered posterior pituitary , etc, and lyophilized powders for injection and small volume injections. Chorionic gonadotropin (hCG), menotropins (hMG) APIs and injections are main products. Chorionic gonadotropin (hCG) were continual twice evaluated “Famous Brand Products of Ningbo” .Lyophilized powder for injections and small volume injections includes Chorionic gonadotropin (hCG) for injection, menotropins (hMG) for injection, co-enzyme A for injection, oxytocin injection and ethylenediamine diaceturate injection, etc.Synthetic APIs and Pharmaceutical Intermediates: The manufacturing site, located in Ningbo Chemical Zone at 255 Beihai Road, Xiepu, occupies a land area of 70,000 square meters. It produces synthetic APIs and pharmaceutical intermediates. The company is the leading producer for 2-aminobenzophenones in terms of variety and quality. 2-Aminobenzophenones project attained National Innovation Fund in 2001 and patent was granted. Paroxetine, a new generation of anti-despondent medicine, obtained subsidization from “Doctoral Fund of Ningbo 2002”. The company has a strong R&D team consists of young dynamic graduates from pharmaceutical universities and institutes. The R&D center of the company has developed 100 products in last 6 years, in which more than 30 are in commercial production.Ningbo No. 2 Hormones Factory, a subsidiary of the company, located at 398 Beierhuan Road ., Cixi, is a specialized in producing veterinary medicines for fish and animal use. Ningbo No. 2 Hormones Factory, licensed by Zhejiang Provincial Department of Agriculture, was passed veterinary GMP inspection by China Agriculture Department in Feb. 2006. It produces lyophilized powder injections, small volume injections and some APIs. Main products are chorionic gonadotropin (hCG) for injection, luteinizing hormone releasing hormone A2 (LHRH-A2 )for Injection, luteinizing hormone releasing hormone A3 (LHRH-A3) for injection，serum gonadotrophinum for injectione，progesterone injection, etc. The marketing covers all over the China and Southeast Asian countries and regions.